Type and hit ENTER

ProAxsis Limited is a commercial-stage diagnostics company, based in Northern Ireland, and with a rapidly growing client list of pharmaceutical companies and academic laboratories.

ProAxsis specialises in four key areas of business:

ProteaseTag®
Active Neutrophil Elastase Immunoassay
  • Our ProteaseTag® immunoassay for measuring active neutrophil elastase was registered with a CE Mark in 2016, and immunoassays for other protease targets are in development.
NEATstik®
Neutrophil Elastase Airways Test
  • Rapid point-of-care tests – NEATstik®, a lateral flow test for measuring active neutrophil elastase at point-of-care, was registered with a CE Mark in September 2017.
Clinical research services
services for both academic and pharmaceutical company researchers
  • Our experienced team can provide a number of services for both academic and pharmaceutical company researchers, and are able to offer sample analysis at our purpose-built laboratory for a range of proteases and other inflammatory biomarkers.
R&D Projects
are supported by a variety of external partners
  • ProAxsis has a number of R&D projects ongoing, whch are supported by a variety of external partners. We are also able to conduct bespoke R&D projects at the request of academic groups or pharmaceutical companies.

ProteaseTag® immunoassay - Activity-based immunoassay kits

Activity-based immunoassay kits – Our ProteaseTag® immunoassay for measuring active neutrophil elastase was registered with a CE Mark in 2016, and immunoassays for other protease targets are in development.

Rapid point-of-care tests – NEATstik®

Rapid point-of-care tests – NEATstik®, a lateral flow test for measuring active neutrophil elastase at point-of-care, was registered with a CE Mark in September 2017.

Activity-based immunoassay kits

Activity-based immunoassay kits – Our ProteaseTag® immunoassay for measuring active neutrophil elastase was registered with a CE Mark in 2016, and immunoassays for other protease targets are in development.

Rapid point-of-care tests – NEATstik®

Rapid point-of-care tests – NEATstik®, a lateral flow test for measuring active neutrophil elastase at point-of-care, was registered with a CE Mark in September 2017.

Clinical research services

Our experienced team can provide a number of services for both academic and pharmaceutical company researchers, and are able to offer sample analysis at our purpose-built laboratory for a range of proteases and other inflammatory biomarkers.

R&D Projects

ProAxsis has a number of R&D projects ongoing, whch are supported by a variety of external partners. We are also able to conduct bespoke R&D projects at the request of academic groups or pharmaceutical companies.

Welcome to ProAxsis

ProAxsis is developing a range of products for the capture, detection and measurement of active protease biomarkers of disease, using its patented ProteaseTag® technology.

ProAxsis specialises in four key areas of business:-

  • Activity-based immunoassay kits – Our ProteaseTag® immunoassay for measuring active neutrophil elastase was registered with a CE Mark in 2016, and immunoassays for other protease targets are in development.

 

  • Rapid point-of-care tests – NEATstik®, a lateral flow test for measuring active neutrophil elastase at point-of-care, was registered with a CE Mark in September 2017.

 

  • Clinical research services – Our experienced team can provide a number of services for both academic and pharmaceutical company researchers, and are able to offer sample analysis at our purpose-built laboratory for a range of proteases and other inflammatory biomarkers.

 

  • R&D Projects – ProAxsis has a number of R&D projects ongoing, whch are supported by a variety of external partners.  We are also able to conduct bespoke R&D projects at the request of academic groups or pharmaceutical companies.

As part of its continuing expansion, ProAxsis Limited, the Belfast-based diagnostics company, is pleased to announce further key appointments within its Northern Ireland team.  Dr Louise Ryan Murphy joins the company as Head of Business Operations.  Louise brings a wealth of operational experience to ProAxsis, having previously …

July 26, 2022

Presenting the high-achieving NI companies hoping for Belfast Telegraph Business Awards 2022 success – BelfastTelegraph.co.uk The team at ProAxsis Limited is delighted to have been shortlisted in the Best Established Small Business category of the 2022 Belfast Telegraph Business Awards.  We’re looking forward to the Awards evening …

May 17, 2022

ProAxsis Limited (www.proaxsis.com), the Belfast-based respiratory diagnostics company, has successfully completed the Performance Evaluation study of the COVID-19 antibody test, initially created by AstraZeneca, with impressive results. The assay has exceptional levels of sensitivity and specificity of 100% and 99.3% respectively, and enables the SARS-CoV-2 antibodies to …

May 16, 2022
GET CONNECTED
RECENT POSTS
ABOUT ME
LIFESTYLE
SHOP ONLINE
old Home - ProAxsis